Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D000605:Amino Alcohols / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000188:drug therapy* / Q000503:physiopathology; D001794:Blood Pressure / Q000187:drug effects; D005080:Exercise Test; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D005996:Nitroglycerin / Q000627:therapeutic use; D005082:Physical Exertion; D010919:Placebos; D011433:Propranolol / Q000627:therapeutic use; D013565:Sympatholytics / Q000494:pharmacology / Q000627:therapeutic use*; D013607:Tablets
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D010919:Placebos; D013565:Sympatholytics; D013607:Tablets; D011433:Propranolol; D005996:Nitroglycerin